Bronx A1c: Bring it Down for Health

布朗克斯 A1c：为了健康而降低它

• 批准号: 8069142
• 负责人: ELIZABETH A. WALKER
• 金额: $ 43.76万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8069142
• 关键词: Address; Adult; Age; Behavior; Behavioral; Caring; Case Manager; Chronic; Clinical; Clinical Management; Clinical Trials; Collaborations; Communicable Diseases; Complications of Diabetes Mellitus; Computerized Medical Record; Coronary heart disease; Data; Databases; Demographic Factors; Diabetes Mellitus; Diabetic Angiopathies; Disease; Electronics; Eligibility Determination; Epidemic; Federally Qualified Health Center; Feedback; Glycosylated Hemoglobin; Glycosylated hemoglobin A; Goals; Health; Health Personnel; Health Policy; Health behavior; Health care facility; Hospitalization; Income; Individual; Informed Consent; Insulin; Insulin-Dependent Diabetes Mellitus; Intervention; Kidney Diseases; Laboratories; Left; Life Style; Link; Literature; Low income; Mails; Maintenance; Measures; Mediating; Medical; Medicine; Mental Depression; Mental Health; Metabolic Control; Neighborhoods; Neuropathy; New York; New York City; Non-Insulin-Dependent Diabetes Mellitus; Outcome; Outcome Study; Patient Education; Patient Self-Report; Patients; Pattern; Policies; Population; Population Attributable Risks; Population Surveillance; Prevalence; Prevention; Printing; Problem Solving; Process; Provider; Psychosocial Factor; Public Health; Quality of Care; Randomized; Randomized Controlled Trials; Records; Registries; Reporting; Research Personnel; Research Training; Retinal Diseases; Risk; Risk Reduction; Sampling; Screening procedure; Secondary Prevention; Self Management; Staging; System; Telephone; Testing; Translations; Uncertainty; United Kingdom; United States Department of Veterans Affairs; Walkers; Woman; base; cardiovascular disorder risk; college; cost; design; diabetes control; diabetes management; effective therapy; evidence base; follow-up; glycemic control; health practice; high risk; improved; innovation; intervention effect; medication compliance; meetings; men; mortality; patient oriented; programs; prospective; psychosocial; response; risk perception; sex; therapy design; type I and type II diabetes; urban area

DESCRIPTION (provided by applicant): Metabolic control of diabetes, measured by hemoglobin A1c (HbA1c), reduces the risk of microvascular complications. Health care providers frequently do not meet standards for managing HbA1c and individuals with diabetes are often not aware of their HbA1c values. To address these issues and reduce population- attributable risk due to elevated HbA1c, the New York City Department of Health and Mental Hygiene (DOHMH) developed an innovative HbA1c registry, which requires all major laboratories to report HbA1c results electronically. We propose to utilize this registry to conduct a randomized controlled trial addressing the following specific aims: 1) to evaluate the incremental effect of a tiered and tailored, patient-centered telephone intervention, in English and Spanish, on the mean HbA1c levels beyond that achieved with print materials mailed to patients and providers by the DOHMH registry intervention; 2) determine what patient demographic and psychosocial factors mediate the effect of the interventions; and 3) provide estimates of implementation costs of the tiered, tailored telephone intervention for comparison with the print intervention. The individual is the unit of sampling, assignment and analysis. After eligibility is assessed and informed consent is obtained by telephone, the individual will be randomly assigned to one of the two groups. The patient telephone intervention will focus on collaborative problem solving for resolving barriers to medication adherence, improving lifestyle behaviors, and communicatiing effectively with their providers. The print materials from the DOHMH will communicate HbA1c results to patients and their providers, with strategies to improve them. The study outcome will be change in HbA1c values from the registry records from baseline to one-year post-randomization. A total of 941 individuals with diabetes will be needed to provide 83% power to detect a statistically significant difference (p<0.05) between groups of at least 0.3% in absolute HbA1c. Psychosocial data on depression, health behaviors, and risk perceptions will be collected by telephone. Intervention cost data will be evaluated for translation of findings and scalability. At study end, we will know the extent to which this intervention will improve metabolic control in a low-income, multi-ethnic sample who are part of the DOHMH HbA1c registry in the South Bronx, New York. These findings will inform public health policies and practices in New York City, as well as other urban areas throughout the nation.

描述（由申请人提供）：通过血红蛋白A1 c（HbA 1c）测量的糖尿病代谢控制可降低微血管并发症的风险。卫生保健提供者经常不符合管理HbA 1c的标准，糖尿病患者经常不知道他们的HbA 1c值。为了解决这些问题并降低由于HbA 1 c升高而引起的人群归因风险，纽约市卫生和心理卫生部（DOHMH）开发了一种创新的HbA 1 c登记系统，该系统要求所有主要实验室以电子方式报告HbA 1 c结果。我们建议利用该登记研究进行一项随机对照试验，以解决以下具体目标：1）评价分层和定制的、以患者为中心的电话干预（英语和西班牙语）对平均HbA 1c水平的增量影响，该影响超出DOHMH登记研究干预邮寄给患者和提供者的印刷材料所达到的水平; 2）确定哪些患者人口统计学和心理社会因素介导了干预的效果; 3）提供分层的、定制的电话干预的实施成本估计，以与印刷干预进行比较。个人是抽样、分配和分析的单位。在通过电话评估合格性并获得知情同意后，将受试者随机分配至两组之一。患者电话干预将侧重于协作解决问题，以解决药物依从性障碍，改善生活方式行为，并与其提供者进行有效沟通。DOHMH的印刷材料将向患者及其提供者传达HbA 1c结果，并提供改善策略。研究结局将是登记研究记录中HbA 1c值从基线至随机化后1年的变化。总共需要941名糖尿病患者提供83%的把握度，以检测绝对HbA 1c至少为0.3%的组间统计学显著差异（p<0.05）。将通过电话收集有关抑郁症、健康行为和风险认知的社会心理数据。将对干预成本数据进行评估，以了解结果的转化和可扩展性。在研究结束时，我们将了解这种干预措施将在多大程度上改善纽约南布朗克斯DOHMH HbA 1c登记的低收入、多种族样本的代谢控制。这些发现将为纽约市以及全国其他城市地区的公共卫生政策和实践提供信息。